Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Focusing on short term investment goals can yield quick financial returns. Discover the right timing for your investment strategy.
27,474 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
OpenAI leads the 2026 IPO chatter, with Stripe and Consensys jockeying for position as investors weigh odds, valuatio...
Eric Trump’s American Bitcoin announced a 1-for-15 reverse stock split to protect its Nasdaq listing as its treasury ...
Apple's dependable cash flow and dividends meet a challenging, transforming Tesla. As 2026 unfolds, investors weigh w...
A transformative bid, a larger regulated footprint, and a path to AI-era resilience. Explore how NextEra Energy's Dom...
Amazon expands its AI funding spree, locking in another $17.5 billion in external financing as total external funding...
As Tesla prepares for its July 22 report, investors are focused on margin expansion, software and services momentum, ...
On Mar. 12, a niche tech partnership caused a notable move in the stock market today landscape. Ondas jumped after li...
An in-depth look at Workhorse's path in 2026, focusing on earnings potential, drivers, and strategies for investors n...
If SpaceX goes public, the market could shift toward a new era of space commerce. This guide breaks down the three cr...
AMD signals a shift from pure CPUs to AI acceleration, blending edge and cloud compute. This article breaks down what...
UPS sits at the crossroads of everyday commerce and global logistics. This guide breaks down the five things every in...